There is significant interest inZTS by institutional investors. The 95.43% of outstanding shares they control represents a greater percentage of ownership than at any other company in the Pharmaceuticals: Generic industry. Additionally, during the quarter ended June 2014, these large investors purchased a net $6.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
INDEPENDENT FRANCHISE PARTNERS, ... Bought 9.9 Million shares of Zoetis Inc
T. ROWE PRICE ASSOCIATES, INC. Bought 7.0 Million shares of Zoetis Inc
LAZARD ASSET MANAGEMENT LLC Bought 3.8 Million shares of Zoetis Inc